Device Trial Radar · NCT07567027
Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR)
Last checked: Nov 20, 2026Latest source record: Jul 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
20
Planned (sponsor's estimate)
Start
Jun 17, 2026
Primary completion
Dec 1, 2027
Study completion Jun 1, 2028
Sponsor
- Lead sponsor
- NYU Langone HealthAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 5, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated device
- Yes
- Who can join
- Male only, from 40 years, up to 95 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the feasibility, safety, and potential protective benefit of Barrigel, a hyaluronic acid-based rectal spacer, in patients undergoing prostate cryoablation for localized or recurrent prostate cancer. The primary aim is to assess Barrigel thermal stability during cryoablation.
Conditions
- Prostate Cancer (Diagnosis)
- Transperineal Cryoablation
Interventions
Barrigel Injectable GelDevice
Barrigel is a hyaluronic acid-based absorbable perirectal spacer.
CryoablationProcedure
Minimally invasive treatment for both localized and recurrent prostate cancer.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of cases in which Barrigel remains unfrozen (temperature maintained above 0°C throughout the freeze cycles)Time frame: End of procedure (up to 4 hours)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
NYU Langone Health
New York, New York · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.